These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1100898)

  • 21. Limited value of in vitro techniques for the detection of leukocyte alloantibodies during granulocyte transfusion therapy.
    Wiesneth M; Pflieger H; Goldmann SF; Arnold R
    Vox Sang; 1981; 40(6):416-21. PubMed ID: 7027623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk of immunization to blood cells and diagnostic and therapeutic implications].
    Kiefel V
    Beitr Infusionsther; 1993; 31():44-51. PubMed ID: 7693263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic effects of leukocytes present in transfused cellular blood products.
    Bordin JO; Heddle NM; Blajchman MA
    Blood; 1994 Sep; 84(6):1703-21. PubMed ID: 8080981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)].
    Höcker P; Pittermann E; Mann M; Krasa E
    Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell alloimmunization in transfused patients with bone marrow failure syndromes.
    Cohen D; Hartung H; Evans P; Friedman DF; Chou ST
    Transfusion; 2016 Jun; 56(6):1314-9. PubMed ID: 27080340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supportive care of patients with bone marrow failure.
    Epstein RB
    Postgrad Med; 1974 May; 55(5):191-6. PubMed ID: 4596318
    [No Abstract]   [Full Text] [Related]  

  • 27. Bone marrow failure: current concepts of pathophysiology and management.
    Epstein RB
    Surg Annu; 1978; 10():53-72. PubMed ID: 416509
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukocyte reduction in blood component therapy.
    Lane TA; Anderson KC; Goodnough LT; Kurtz S; Moroff G; Pisciotto PT; Sayers M; Silberstein LE
    Ann Intern Med; 1992 Jul; 117(2):151-62. PubMed ID: 1605430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Febrile transfusion reaction following initial transfusion in a man with immunoblastic lymphadenopathy and granulocyte autoantibodies.
    Barnes HM; Poon MC; Huang ST; Conrad ME; Lin J; McGowan EI
    Am J Hematol; 1983 Feb; 14(1):97-100. PubMed ID: 6837570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Supportive therapy for pronounced bone marrow insufficiency with special reference to granulocytopenia].
    Stacher A; Höcker P; Baumgartner G
    Haematol Blood Transfus; 1978; 21():433-40. PubMed ID: 738647
    [No Abstract]   [Full Text] [Related]  

  • 32. ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion.
    Zaffuto BJ; Conley GW; Connolly GC; Henrichs KF; Francis CW; Heal JM; Blumberg N; Refaai MA
    Vox Sang; 2016 Apr; 110(3):219-26. PubMed ID: 26528766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse reactions due to leucocyte and platelet antibodies.
    Bashir H
    Anaesth Intensive Care; 1980 May; 8(2):132-8. PubMed ID: 7396177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet and leukocyte transfusions in acute leukemia.
    McCredie KB; Hester JP; Freireich EJ; Brittin GM; Vallejos C
    Hum Pathol; 1974 Nov; 5(6):699-708. PubMed ID: 4607955
    [No Abstract]   [Full Text] [Related]  

  • 35. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological complications of blood transfusions.
    Brand A
    Presse Med; 2016; 45(7-8 Pt 2):e313-24. PubMed ID: 27499223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of platelet alloimmunization.
    Slichter SJ
    Prog Clin Biol Res; 1986; 211():83-116. PubMed ID: 3515365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review.
    Verduin EP; Brand A; Schonewille H
    Transfus Med Rev; 2012 Oct; 26(4):342-53, 353.e1-5. PubMed ID: 22244869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological aspects of transfusion therapy.
    Engelfriet CP; Pegels JG; von dem Borne AE
    Bibl Haematol; 1980; (46):120-31. PubMed ID: 6990910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.